Scinovex
review Open AccessTop 1% cited

Cardiovascular prevention and blood pressure reduction

Journal of Hypertension · 2003 · Vol. 21(6) · pp. 1055–1076

Abstract

The hypothesis that new antihypertensive drugs, such as calcium-channel blockers, alpha-blockers, ACE inhibitors or AR1 blockers might influence cardiovascular prognosis over and beyond their antihypertensive effects remains unproven. The finding that blood pressure differences largely accounted for cardiovascular outcome emphasizes the desirability of tight blood pressure control. However, the level to which blood pressure must be lowered to achieve maximal benefit remains currently unknown.

Blood Pressure and Hypertension StudiesHormonal Regulation and HypertensionRenin-Angiotensin System StudiesMedicineBlood pressureMyocardial infarctionInternal medicineCardiologyStroke (engine)Odds ratioClinical trialVerapamilRandomized controlled trial

MeSH terms

Antihypertensive AgentsHeart DiseasesHumansHypertensionRandomized Controlled Trials as TopicStroke
Citations
487
FWCI
34.02
field-weighted impact
References
146
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.